McCormick’s third-quarter net sales rose 17.4% from a year earlier, with 0.9 percentage points of that increase coming from ...
Ovintiv renewed its annual share buyback program and set a new repurchase target of up to 26,973,037 common shares over the ...
Matthews International said two long-serving directors, Katherine E. Dietze and Morgan K. O’Brien, will not stand for ...
Brookfield said Oaktree’s Asset-Backed Finance Fund, or ABF I, closed with $2 billion of commitments, hitting its target ...
First Merchants Corporation said CEO Mark Hardwick will retire at the end of 2026 after 29 years with the bank, and President ...
TTM Technologies completed its $1.1 billion cash acquisition of Epiq Design Solutions on September 30, adding a business ...
D-Wave Quantum on Oct. 1 launched a beta program for its gate-model quantum computing simulator, giving a first group of customers early access to software tied to its forthcoming gate-model systems.
Monte Rosa Therapeutics said its lead inflammatory-disease drug candidate, MRT-8102, cut multiple cardiovascular risk biomarkers in a phase 1 study of 108 obese subjects with elevated cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results